Clinical studies confirmed that NAD+ precursors such as nicotinamide riboside could enhance mitochondrial metabolism by restoring SIRT3 activity, partially improving cognitive function in AD patients (Wang et al., 2021). The gene discussed is SIRT3; the disease is Alzheimer disease.